Wellinks Raises $10M Series B
Wellinks, based in New Haven, Connecticut, is a digital health provider specializing in cardiopulmonary remote patient monitoring. The company has secured $10M as the first tranche of its Series B funding round.
The funding round was led by strategic partner UMass Memorial Health, with participation from existing inside investors.
Capital proceeds will be used to expand the company's commercial footprint into rural and underserved markets, advance their predictive analytics engines, and extend their care model into the treatment of Congestive Heart Failure.
Founded in New Haven, Wellinks provides an FDA-cleared remote patient monitoring system and proprietary health tags that deliver continuous physiological tracking to predict clinical deterioration in patients, specifically targeting conditions like COPD.
Funding Details
Company Website: https://wellinks.com
Company: Wellinks
Raised: $10M
Round: Series B
Funding Date: August 5, 2026
Lead Investor: UMass Memorial Health
Additional Investors: Existing inside investors
Software Category: Digital Health